S
SMMT icon

SignatureFD’s Summit Therapeutics SMMT Stock Holding History

SignatureFD’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11K Sell
76
-20
-21% -$355 ﹤0.01% 3247
2026
Q1 		$1.82K Buy
96
+18
+23% +$291 ﹤0.01% 3080
2025
Q4 		$1.36K Sell
78
-74
-49% -$1.39K ﹤0.01% 3061
2025
Q3 		$3.14K Buy
+152
New +$3.69K ﹤0.01% 2813
2025
Q2 		– Sell
-9
Closed -$174 – 3414
2025
Q1 		$174 Buy
+9
New +$181 ﹤0.01% 3250
2024
Q4 		– Sell
-21
Closed -$460 – 3395
2024
Q3 		$460 Hold
21
– – ﹤0.01% 3112
2024
Q2 		$164 Sell
21
-103
-83% -$556 ﹤0.01% 3058
2024
Q1 		$513 Buy
124
+103
+490% +$409 ﹤0.01% 3027
2023
Q4 		$55 Sell
21
-2,589
-99% -$5.33K ﹤0.01% 3095
2023
Q3 		$4.88K Buy
2,610
+2,188
+518% +$4.17K ﹤0.01% 2506
2023
Q2 		$1.06K Sell
422
-2,858
-87% -$5.22K ﹤0.01% 2960
2023
Q1 		$5.74K Buy
3,280
+3,236
+7,355% +$8.83K ﹤0.01% 2454
2022
Q4 		$187 Buy
+44
New +$80 ﹤0.01% 3195
2022
Q1 		– Sell
-199
Closed -$1K – 3312
2021
Q4 		$1K Sell
199
-960
-83% -$4.61K ﹤0.01% 2993
2021
Q3 		$6K Sell
1,159
-408
-26% -$2.93K ﹤0.01% 2299
2021
Q2 		$12K Buy
1,567
+678
+76% +$4.45K ﹤0.01% 1926
2021
Q1 		$5K Buy
889
+483
+119% +$3.12K ﹤0.01% 2168
2020
Q4 		$2K Buy
+406
New +$1.72K ﹤0.01% 2306

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SignatureFD's SMMT Position: Q2 2026 in Review

SignatureFD reduced its Summit Therapeutics (SMMT) stake by 21% in Q2 2026, selling an estimated $355 and leaving 76 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #3247.

SignatureFD first reported a position in SMMT in Q4 2020 and has held it in 18 quarters since. The position peaked at $12K in Q2 2021. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • SignatureFD held 76 shares of Summit Therapeutics worth $1.11K as of Q2 2026.
  • SignatureFD sold 20 Summit Therapeutics shares in Q2 2026, an estimated $355.
  • Summit Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3247 holding.
  • SignatureFD first reported a position in Summit Therapeutics in Q4 2020 and has held it in 18 quarters since.
  • SignatureFD's Summit Therapeutics position peaked at $12K in Q2 2021.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.